{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-053689","form_type":"8-K","ticker":"VCYT","cik":"0001384101","company_name":"VERACYTE, INC.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.014859+00:00","generated_at":"2026-06-05T06:28:03.908013+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Veracyte registers 1.68M shares for resale related to C2i Genomics acquisition","bullets":["Filed prospectus supplement to register up to 1,681,384 shares of common stock for resale.","Shares were issued in connection with the acquisition of C2i Genomics, Inc. on Feb 5, 2024.","Includes opinion of counsel (Fenwick & West) on legality of the shares.","This is a procedural step; no new financial or operational information."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-053689","json":"https://secwatch.observer/filing/0001193125-24-053689.json","markdown":"https://secwatch.observer/filing/0001193125-24-053689.md","text":"https://secwatch.observer/filing/0001193125-24-053689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1384101/000119312524053689/0001193125-24-053689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1384101/000119312524053689/d799495d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:28:03.908013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}